M itochondria are central to eukaryotic aerobic metabolism. One consequence arising from the shuttling of electrons onto molecular oxygen during mitochondrial respiration is the formation of reactive oxygen species (ROS). Given the resultant necessity and subsequent ubiquity of ROS formation, it is not surprising then that these generally toxic products of metabolism also function as purposeful second messenger molecules.
expression. Ca 2+ and ROS as second messenger signaling molecules share at least 4 key attributes relevant to this study: first, Ca 2+ and ROS signaling events are known to be functionally coupled 10, 11 ; second, Ca 2+ and ROS signaling cascades attain specificity, in part, by subcellular compartmentalization 12, 13 ; third, Ca 2+ and ROS signaling events are influenced by mitochondria 10 ; and fourth, Ca 2+ and ROS signaling cascades are implicated in the development of disease. 11, 14 In accordance with the first 2 attributes, our previous works showed that formation of punctate sites of ROS generation involving nicotinamide adenine dinucleotide phosphate (NADPH) oxidase leads to colocalized Ca 2+ influx through L-type Ca 2+ channels. [15] [16] [17] We found that oxidative activation of protein kinase C (PKC), 18 which promotes localized Ca 2+ influx through L-type Ca 2+ channels, [19] [20] [21] functionally links Ca 2+ and ROS microdomain signaling in this context. Here, we addressed the second pair of Ca 2+ and ROS signaling attributes listed above by investigating mitochondrial ROS-dependent regulation of arterial smooth muscle L-type Ca 2+ channels in relation to the development of hypertension-associated arterial dysfunction.
Experiments were performed on single cells, on excised arterial segments, and in living animals. Using this progressive subcellular in vitro-to-organismal in vivo approach, we conclude that amplification of hydrogen peroxide (H 2 O 2 ) microdomain signaling by subplasmalemmal mitochondria promotes the opening of adjacent L-type Ca 2+ channels and subsequently the development of hypertension-associated arterial dysfunction.
Methods
Male Sprague-Dawley rats were euthanized with sodium pentobarbital (200 mg/kg IP) as approved by the Institutional Animal Care and Use Committee of Colorado State University. Smooth muscle cells were isolated from basilar and cerebral arteries. Confocal microscopy was used to image the plasma membrane and mitochondria of single cells. L-type Ca 2+ channel sparklets and subplasmalemmal ROS were imaged with total internal reflection fluorescence (TIRF) microscopy. 15, 16 Arterial diameters were recorded from middle cerebral arterial segments. Hypertension was induced in rats by including N ω -nitrol-arginine methyl ester (L-NAME) in their drinking water, [22] [23] [24] and arterial blood pressure was monitored by telemetry as approved by the Institutional Animal Care and Use Committee of the University of California, Davis.
Normally distributed data are presented as the mean± SEM. To account for potential variability associated with cell isolation, all single myocyte experimental groups comprised cells obtained from ≥4 rats. Effect sizes, represented in the figures as bracketed values, are reported as Pearson r (range, −1.0 to 1.0; 0 indicates no effect) 25, 26 ; P values <0.05 were considered significant. An expanded Materials and Methods are available in the Online Data Supplement
Results

Subpopulation of Mitochondria Associates With the Arterial Smooth Muscle Cell Plasma Membrane at Sites of Elevated L-type Ca 2+ Channel Activity
To assess the subcellular distribution of mitochondria in arterial smooth muscle, we marked the plasma membrane of cells with a wheat germ agglutinin conjugate (Alexa 555-wheat germ agglutinin [WGA] , red), labeled mitochondria with MitoTracker Green, and visualized the fluorescence with confocal microscopy ( Figure 1A ). We found that 8.64±0.42% of the total cell volume was occupied by mitochondria; this volume is consistent with previous report. 27 Although the majority of the MitoTracker signal was located centrally (>0.5 µm from the center of the Alexa 555-WGA signal), 7.50±0.77% of the mitochondrial volume was peripheral (≤0.5 µm; yellow signal in Figure 1A , panel 3).
Next, we examined MitoTracker-loaded cells with TIRF microscopy. Our images showed regions of MitoTracker fluorescence indicating the presence of subplasmalemmal mitochondria ( Figure 2A , panel 1). Analysis of thresholded MitoTracker images revealed that only 3.29±0.26% (n=7 cells) of the visible plasma membrane was associated with mitochondria ( Figure 2A , panel 2). We imaged Ca 2+ influx with a combination of TIRF microscopy and voltage-clamp electrophysiology. 15, 19, 21 This approach permits visualization of Ca 2+ influx through L-type Ca 2+ channels (Ca 2+ sparklets). To evoke Ca 2+ sparklets, we exposed cells to angiotensin II (Ang II; 100 nmol/L), which is known to promote mitochondrial ROS production. 6 Similar to our previous reports, [15] [16] [17] 28 Ang II induced L-type Ca 2+ channel sparklet sites as revealed by localized changes in fluorescence of the Ca 2+ indicator fluo-5F ( Figure 2A, panel 3 ]) and site densities and activities (see below). [15] [16] [17] To visualize the spatial relationship between L-type Ca 2+ channel activity and subplasmalemmal mitochondria, we overlaid our fluo-5F and thresholded MitoTracker images ( Figure 2A , panel 4). We then measured the distance from L-type Ca 2+ channel sparklet site peaks (pixels of highest intensity) to the edge of the nearest MitoTracker signal and plotted the cumulative values ( Figure 2B ). Mitochondrial-associated L-type Ca 2+ channel sparklet sites were defined a priori as those sites with peaks ≤0.5 µm from the edge of the nearest thresholded MitoTracker signal; this is represented by the vertical dashed gray line in Figure 2B . We found that L-type Ca 2+ channel function was associated with subplasmalemmal mitochondria ( Figure 2B ; n=5 cells). The half distance of the observed L-type Ca 2+ channel sparklet sites (n=41 sites) to the nearest mitochondria was 0.43 (95% confidence interval, 0.39-0.47) µm, whereas the half distance of 100 random points within the visible plasma membrane to the nearest mitochondria was 2.10 (95% confidence interval, 1.99-2.19) µm.
Next, we compared the activity of mitochondrial-associated (distance, ≤0.5 µm) and nonassociated L-type Ca 2+ channel sparklet sites. L-type Ca 2+ channel sparklet site activity can be expressed by the descriptor nP s , where n is the number of quanta detected (ie, number of functional channels) and P s is [15] [16] [17] 20 As mitochondria are a major source of ROS, we tested the hypothesis that localized H 2 O 2 generated by subplasmalemmal mitochondria stimulate nearby L-type Ca 2+ channels. To promote mitochondrial ROS generation, we exposed cells to the electron transport chain complex III inhibitor antimycin (500 nmol/L). 29, 30 First, we investigated the effect of antimycin on subplasmalemmal ROS production with the fluorescent ROS indicator 5-(and-6)-chloromethyl-2′7 ′-dichlorodihydrofluorescein diacetate acetyl ester (DCF; 1 µmol/L) and monitored for changes in subplasmalemmal fluorescence ( Figure 3A ). Similar to Ang II, 15, 16 antimycin induced localized sites of elevated DCF fluorescence (ROS puncta 15 ; Figure 3A and 3B; P<0.05; r=0.65; n=5 cells); comparably ROS puncta formation was not apparent in time-matched controls. In contrast to the ≈6-fold increase in DCF fluorescence associated with ROS puncta, the spatially averaged DCF fluorescence in cells treated with antimycin did not increase (Online Figure IA; P>0.05; n=5 cells). This observation is consistent with the concept of localized ROS generation by subplasmalemmal mitochondria.
Antimycin also induced localized L-type Ca 2+ channel sparklets ( Figure 3C and 3D Figure IB and IC). These data are consistent with the hypothesis that antimycin-dependent promotion of localized mitochondrial H 2 O 2 generation stimulates neighboring L-type Ca 2+ channels via a PKC-dependent mechanism.
Our previous work and results using the NADPH oxidase inhibitor ML171 (Online Figure III) indicate that NADPH oxidase activity is necessary for local regulation of L-type Ca 2+ channels by Ang II-induced H 2 O 2 microdomain signaling. 15, 16 Ang II also induces mitochondrial ROS generation. 6 ,31
Therefore, we tested the effect of inhibiting mitochondrial ROS generation on Ang II-dependent stimulation of L-type Ca 2+ channels. The mitochondrial-targeted antioxidant mitoTEMPO attenuates the production of H 2 O 2 by mitochondria in response to Ang II. 6, 8, 31, 32 We found that Ang II did not promote ROS puncta formation in cells pretreated with mitoTEMPO (25 nmol/L for 15 minutes; Figure 4A and 4B; P>0.05; In control experiments, Ang II constricted arteries to 14.86±0.99% below their baseline diameter ( Figure 5A ). In arteries incubated with mitoTEMPO (1 µmol/L for 15 minutes), Ang II induced a smaller contraction to only 3.98±0.99% below baseline ( Figure 5B ; P<0.05; r=−0.93; n=5 arteries). MitoTEMPO by itself had no apparent effect on baseline arterial constriction or the contractile response to 60 mmol/L KCl (P>0.05; n=3 arteries, data not shown). We reported previously that the nontargeted antioxidant TEMPOL does not suppress Ang II-dependent stimulation of L-type Ca 2+ channels. 16 Therefore, we replicated our contractile experiments with Ang II on arteries incubated with TEMPOL (10 µmol/L for 15 minutes). In contrast to mitoTEMPO, even at 10-fold higher concentration, TEMPOL did not reduce Ang II-dependent arterial constriction (Figure 5C and 5D; P>0.05; r=−0.29; n=5 arteries). From these data, we conclude that mitochondrialderived ROS contribute to Ang II-dependent constriction of pressurized intact arterial segments.
Reducing Mitochondrial ROS Production In Vivo Attenuates Hypertensive Arterial Responses to Endothelial Dysfunction
To establish the importance of smooth muscle mitochondrial ROS production on arterial function in vivo, we induced hypertension in rats by including the nitric oxide synthase inhibitor N ω -nitro-l-arginine methyl ester (L-NAME; 0.75 mg/ mL) in their drinking water (dose ≈50 mg/kg per day). [22] [23] [24] A key feature of L-NAME-induced hypertension is frank To examine the involvement of mitochondrial-derived ROS, we infused L-NAME-treated animals with mitoTEMPO at a rate of 150 µg/kg per day 8 via subcutaneous osmotic minipumps; rats implanted with saline minipumps served as control. Arterial blood pressure was monitored by telemetry.
L-NAME induced a time-dependent increase in mean arterial pressure ( Figure 6A ; P<0.05; r=0.98; n=5 rats). Similar to Ang II-induced hypertension, 8 coadministration of mitoTEMPO blunted (r=-0.72) the hypertensive response to L-NAME ( Figure 6B ; P<0.05; r=0.82; n=5 rats). The effect of mitoTEMPO on mean arterial pressure was evident on the third day of L-NAME treatment ( Figure 6C ; P<0.05; r=-0.96). Thus, despite continued disruption of endothelial function, mitoTEMPO produced a modest decrease in blood pressure. This observation suggests that mitoTEMPO could be working in vivo, at least in part, by reducing mitochondrial ROS generation and subsequent stimulation of arterial smooth muscle L-type Ca 2+ channels. To investigate this, we excised arterial segments from L-NAME and L-NAME plus mitoTEMPO-treated animals and compared their myogenic set points (ie, observed levels of myogenic tone). First, we pressurized arteries to 20 mm Hg and allowed them to equilibrate. Once a stable diameter was reached, we increased the pressure to 60 mm Hg and waited for an active myogenic contractile response to occur after passive dilation ( Figure 6C ). Experiments were terminated by superfusing the arteries with a nominally Ca 2+ -free solution. Arteries isolated from L-NAME-treated animals infused with saline constricted robustly when the intraluminal pressure was increased from 20 to 60 mm Hg (48.80±2.06% below passive diameter; n=5 arteries). Arteries from L-NAME-treated animals infused with mitoTEMPO constricted substantially less after the same increase in pressure (30.43±1.46% below passive diameter; P<0.05; r=-0.92; n=5 arteries). Note that arteries isolated from normotensive rats pressurized to 60 mm Hg constricted to 38.29±3.20% below their passive diameter (n=5 arteries), which was smaller than the constriction seen in arteries from L-NAME-treated animals infused with saline (P<0.05), but not significantly different from the constriction seen in arteries from L-NAME-treated animals infused with mitoTEMPO (P>0.05). From these data, we conclude that systemic inhibition of mitochondrial ROS generation with mitoTEMPO reduces L-NAME-induced arterial dysfunction in vivo (lowers systemic arterial pressure) and ex vivo (lowers arterial myogenic tone).
To investigate the mechanisms underlying mitoTEMPOdependent preservation of arterial function, we examined baseline ROS and Ca 2+ microdomain signaling activity in cells isolated from these animals. Using DCF fluorescence as an indicator of ROS generation with TIRF microscopy, we found that ROS puncta density (in the absence of acute stimulation) was elevated in smooth muscle cells from hypertensive L-NAME-treated rats when compared with those from non-l-NAME-treated controls (Figure 7A and 7B; P<0.05; r=0.70; n=5 cells). Importantly, ROS puncta densities in cells isolated from rats receiving L-NAME and mitoTEMPO were lower than those receiving L-NAME alone (P<0.05; r=−0.74; n=5 cells). The ROS puncta density in these cells was negligible and not different from unstimulated control cells (P>0.05; n=5 cells).
Paralleling our ROS puncta data and consistent with previous observations in Ang II-induced and genetic hypertension, 28 basal L-type Ca 2+ channel function was enhanced in cells isolated from hypertensive L-NAME-treated rats as evidenced by elevated Ca 2+ sparklet site activities and densities (Figure 7C and 7D; P<0.05; nP s r=0.75; density r=0.64; n=5 cells). Notably, as with ROS puncta, mitoTEMPO infusion abolished L-NAME enhancement of L-type Ca 2+ channel activity (P<0.05; r=−0.51; n=5 cells) with levels not different from unstimulated cells from normotensive animals (P>0.05; n=5 cells). Taken altogether, we conclude that arterial smooth muscle mitochondrial-amplified H 2 O 2 microdomain signaling promotes Ca 2+ influx through neighboring L-type Ca 2+ channels, and that this process contributes mechanistically to the contractile action of Ang II and the development of hypertension-associated arterial dysfunction.
Discussion
In this study, we tested the hypothesis that mitochondrial amplification of H 2 O 2 microdomain signaling stimulates L-type Ca 2+ channels in arterial smooth muscle. The major findings supporting this hypothesis are (1) subplasmalemmal mitochondria associate with sites of elevated L-type Ca 2+ channel activity; (2) mitochondrial-derived H 2 O 2 stimulates Ca 2+ influx through L-type channels; (3) inhibiting mitochondrial H 2 O 2 production reduces Ang II-mediated arterial contraction; and (4) inhibiting mitochondrial H 2 O 2 production attenuates the development of hypertension-associated arterial smooth muscle dysfunction ex vivo and in vivo. From these data, we conclude that mitochondrial amplification of H 2 O 2 microdomain signaling is an important regulator of L-type Ca 2+ channels in arterial smooth muscle and contributes to the development of hypertension-associated arterial dysfunction. Our imaging of subplasmalemmal fluo-5F and MitoTracker fluorescence with TIRF microscopy provides compelling evidence that L-type Ca 2+ channel activity is enriched at areas of the plasma membrane associated with mitochondria ( Figure 2 ). Consistent with this observation, the small amount of plasma membrane associated with mitochondria (≈5%) is sufficient to influence the surface area necessary (≈4%) to accommodate the L-type Ca 2+ channel sparklet activity observed. This logic supports the conclusion that subcellular localization is a key factor in determining the stimulatory influence of mitochondria on L-type Ca 2+ channels (Online Data Supplement iii).
Evidence suggests that mitochondrial buffering of proximate Ca 2+ flux events is an important mechanism by which these organelles influence Ca 2+ signaling. 35 2 ). This is in contrast to the effects of NADPH oxidase inhibition and catalase on Ang IIdependent L-type Ca 2+ channel sparklets where activity and density are reduced. 15, 16 Although initially perplexing, we think that this subtle observation provides valuable mechanistic insight into the signaling events underlying oxidantdependent regulation of L-type Ca 2+ channels. Activation of Ang II type 1 receptors stimulates NADPH oxidase resulting in ROS formation. 40, 41 Evidence suggests that ROS produced by NADPH oxidase can induce subsequent ROS generation from mitochondria through the process of ROSinduced ROS release. 8, 31, 32 If mitochondrial ROS-induced ROS release is necessary for physiological stimulation of L-type Ca 2+ channels by Ang II, then disrupting this process with mitoTEMPO should reduce arterial contractile responses to Ang II. Consistent with this, mitoTEMPO reduced Ang II-dependent contraction of pressurized cerebral arteries by ≈70%. In contrast, MitoTEMPO had no effect on the baseline myogenic tone of these arteries. Similarly, we noted previously that inhibition of NADPH oxidase 15 and application of cell-permeable catalase 16 reduced contractile responses to Ang II without altering arterial tone. These observations suggest that, at least in cerebral arteries from healthy rats, H 2 O 2 microdomain stimulation of smooth muscle L-type Ca 2+ channels contributes to the vasoconstrictor capacity of Ang II but does not influence baseline myogenic function.
In contrast to our observations, work by others has shown that mitochondrial and NADPH oxidase-derived ROS reduce arterial contractility by enhancing activation of hyperpolarizing large-conductance, Ca 2+ -activated potassium (BK) channels. 42, 43 We contend that our H 2 O 2 microdomain signaling hypothesis reconciles these seemingly diametrically opposed observations. In the case of our data, H 2 O 2 microdomain signaling is coupled to the activation of L-type Ca 2+ channels leading to contraction. For vasodilatory-associated ROS, we hypothesize that discrete ROS signaling events are selectively coupled to vasodilatory processes. In addition, we hypothesize that ROS microdomain signaling attains differential coupling specificity as a consequence of distinct subcellular distribution patterns inherent to the underlying ROS-generating mechanisms (Online Data Supplement iv).
Anomalous Ang II signaling is implicated in the development of arterial dysfunction and hypertension. 6, 32, 44 We found that mitoTEMPO attenuated the vasoconstrictive capacity of Ang II, and, conversely, that stimulating mitochondrial ROS production with antimycin increased L-type Ca 2+ channel activity. Therefore, we examined the efficacy of mitoTEMPO in mitigating arterial smooth muscle dysfunction in hypertension. Systemic administration of mitoTEMPO blunts the hypertensive response to Ang II infusion in mice, at least in part, by increasing the bioavailability of nitric oxide and preserving endothelial function. 8 To investigate the effect of mitoTEMPO on arterial smooth muscle function, we used a nitric oxidedeficient model of hypertension where endothelial dysfunction is an causal hallmark. 34, 45 Similar to Ang II infusion, 8 coadministration of mitoTEMPO reduced the hypertensive response to L-NAME. This observation suggests that the antihypertensive effect of mitoTEMPO resides, at least in part, at the level of arterial smooth muscle.
To examine the effect of systemically administered mito-TEMPO on arterial smooth muscle function, we isolated and pressurized cerebral arteries obtained from L-NAME-treated rats. Arteries from these rats contracted to ≈50% below their passive diameter when pressurized to 60 mm Hg. In contrast, arteries from L-NAME-treated rats infused with mitoTEMPO contracted to only ≈30% below their passive diameter. For perspective, the control arteries used in our Ang II/mitoTEM-PO experiments contracted to ≈38% below their passive diameter, which was not significantly different from that seen with mitoTEMPO. Thus, systemically administered mitoTEMPO normalized the intrinsic myogenic set point of arteries isolated from L-NAME-treated rats.
To investigate the mechanisms by which mitoTEMPO normalized arterial function in L-NAME-treated rats, we examined L-type Ca 2+ channel and H 2 O 2 microdomain signaling in isolated cells. Similar to Ang II-dependent and genetic hypertension, 28 basal L-type Ca 2+ channel sparklet activity and ROS puncta density were elevated in cells from hypertensive L-NAME-treated rats. Strikingly, arterial smooth muscle cells isolated from rats infused with mitoTEMPO showed no increase in either ROS puncta density or L-type Ca 2+ channel sparklet activity. From these data, we conclude that mito-TEMPO preserves arterial function and reduces arterial blood pressure, at least in part, by inhibiting mitochondrial amplified H 2 O 2 microdomain-dependent stimulation of arterial smooth muscle L-type Ca 2+ channels. The implications of our observations are broad. First, we suggest that mitochondrial amplification of H 2 O 2 microdomain signaling in arterial smooth muscle is a potentially viable therapeutic target for reducing hypertension-associated arterial dysfunction. Second, because mitochondria and L-type Ca 2+ channels are widely distributed, we suggest that localized mitochondrial amplification of H 2 O 2 microdomain signaling could be a general mechanism for promoting Ca 2+ influx through L-type Ca 2+ channels in many cell types, including cardiac myocytes as demonstrated by others.
46-48
Indeed, we recently described a mechanism responsible for localized L-type Ca 2+ channel function in neuroendocrine pituitary gonadotrope cells, which bears a striking resemblance to our observations in smooth muscle 49 Finally, this mechanism could be an important factor contributing to the exaggerated ROS production and Ca 2+ influx associated with the pathogenesis of numerous cardiovascular and noncardiovascular diseases.
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What New Information Does This Article Contribute?
• Mitochondria residing near the plasma membrane of rat cerebral arterial smooth muscle cells are associated with sites of elevated Ca 2+ influx through L-type Ca 2+ channels.
• Following Ang II exposure, subplasmalemmal mitochondria amplify localized ROS (hydrogen peroxide) production initiated by nicotinamide adenine dinucleotide phosphate oxidase in signaling microdomains resulting in protein kinase C-dependent activation of neighboring L-type Ca 2+ channels.
• This mitochondrial ROS-dependent stimulation of L-type Ca 2+ channels contributes to contraction of rat cerebral arteries by Ang II.
• Disrupting mitochondrial ROS production in vivo normalizes arterial function and attenuates the hypertensive response to pharmacologically induced systemic endothelial dysfunction.
Mitochondria are a major source of cellular ROS. In addition, mitochondrial dysfunction is associated with cardiovascular disease. However, the importance of mitochondrial ROS in Ang II-dependent arterial contraction and in hypertension-associated arterial dysfunction is unclear.
In this study, we tested the hypothesis that mitochondrial ROS generation regulates the activity of L-type Ca 2+ channels in rat cerebral arterial smooth muscle in the context of Ang II signaling. Using an image-based approach, we found that mitochondrial amplification of ROS (hydrogen peroxide) signaling near the plasma membrane stimulates L-type Ca 2+ channels. By providing a means of increased Ca 2+ influx, this mechanism contributes to Ang II-dependent arterial contraction. Our data also show that disrupting this mitochondrial amplification mechanism in vivo normalizes arterial function and attenuates the hypertensive response to systemic endothelial dysfunction. From these observations, we conclude that mitochondrial amplification of hydrogen peroxide signaling leads to increased Ca 2+ influx through L-type Ca 2+ channels. We suggest that this mechanism plays an important role in arterial smooth muscle physiology and contributes to arterial dysfunction in hypertension. We also propose that mitochondrial amplification of ROS signaling in arterial smooth muscle is a potentially viable therapeutic target for reducing hypertension-associated arterial dysfunction.
SUPPLEMENTAL MATERIAL
Detailed Methods
Chemicals.
All chemicals were from Sigma unless stated otherwise.
Isolation of rat cerebral arterial myocytes.
Adult male Sprague-Dawley rats (Harlan) were euthanized with sodium pentobarbital (200 mg/kg intraperitoneally; MWI Veterinary Supply) in accordance with institutional guidelines and approved by the Institutional Animal Care and Use Committee of Colorado State University and the University of California, Davis. Isolated smooth muscle cells were prepared from basilar and cerebral arteries. Arteries were removed, cleaned, and placed in ice-cold Ca 2+ -free buffer containing (mmol/L): 140 NaCl, 5 KCl, 2 MgCl2, 10 glucose, and 10 HEPES (adjusted to pH 7.4 with NaOH). Arteries were incubated for 15 min at 37°C in Ca 2+ -free buffer supplemented with papain (10 U/mL; Worthington Biochemical) and dithiothreitol (1 mg/mL) followed by a second incubation (15 min at 37°C) in Ca
2+
-free buffer supplemented with collagenase (300 U/mL, Type II, Worthington Biochemical). Arteries were then washed with and placed in Ca 2+ -free buffer and kept on ice for 30 min after which trituration with a firepolished Pasteur pipette was used to create a cell suspension; cells were used within 6 h of dispersion.
Confocal microscopy.
Laser scanning confocal microscopy was used to image the plasma membrane and mitochondria. Freshly prepared smooth muscle cell suspensions were pipetted into a glass bottomed recording chamber. The extracellular face of the plasma membrane was marked with a wheat germ agglutinin Alexa 555 conjugate (Life Technologies; 5 µg/mL for 15 min) and mitochondria were labelled with MitoTracker Green (Life Technologies; 1 µmol/L for 15 min). Alexa 555 was excited with a 543 nm laser and MitoTracker Green was excited with a 488 nm laser; excitation and emission light was separated with appropriate filters. Data were analyzed with Volocity 3D Image Analysis Software (PerkinElmer). Mitochondrial-associated fluorescence located ≤0.5µm from the center of the Alex 555-WGA signal was designated as peripheral as this value falls within the predicted functional distance of intracellular signaling H 2O2.
1,2
Electrophysiology.
Smooth muscle cell suspensions were pipetted into a glass bottomed recording chamber and the cells were allowed to adhere for 20 min. Membrane potential was controlled with an Axopatch 200B amplifier (Molecular Devices). The perforated whole-cell patch-clamp technique was used to record macroscopic L-type Ca 2+ channel currents with barium (Ba 2+ ) as the charge carrier. For these experiments the amphotericin B (250 μg/ml) supplemented pipette solution contained (mmol/L): 120 CsCl, 20 TEA-Cl, 1 EGTA, and 20 HEPES (adjusted to pH 7.2 with CsOH) and cells were superfused with an external solution composed of (mmol/L): 115 NaCl, 10 TEA-Cl, 0.5 MgCl2, 5.5 glucose, 5 CsCl, 20 BaCl2, and 20 HEPES (adjusted to pH 7.4 with CsOH).
For our Ca
2+ imaging experiments, we used the conventional dialyzed whole-cell patch-clamp technique. During these experiments cells were superfused with a solution containing (mmol/L): 120 NMDG + , 5 
Total internal reflection fluorescence (TIRF) microscopy.
Ca 2+ influx through L-type channels was visualized with a TILL Photonics through-the-lens TIRF system built around an inverted Olympus IX-71 microscope using a 100X (numerical aperture = 1.45) TIRF oilimmersion objective and an Andor iXON EMCCD camera. To monitor Ca 2+ influx, myocytes were loaded with the Ca 2+ indicator fluo-5F (200 µmol/L; pentapotassium salt; Invitrogen) and an excess of EGTA (10 mmol/L) via the patch pipette. To preclude potential contaminating Ca 2+ release events from the sacroplasmic reticulum, the Ca 2+ -ATPase inhibitor thapsigargin (1 µmol/L) was present during all experiments. Excitation of fluo-5F was achieved with a 491 nm laser and excitation and emission light was separated with appropriate filters. Ca 2+ influx was recorded at 50 Hz at a holding potential of -70 mV and elevated external [Ca 2+ ] (20 mmol/L) to facilitate the detection of events and provide fluorescent signals of sufficient amplitude 3 to permit quantal analysis.
L-type Ca 2+ channel sparklet analysis.
Background-subtracted fluo-5F fluorescence signals were converted to [Ca 2+ ] 3-5 using the equation
where F is fluorescence, Fmax is the fluorescence intensity of fluo-5F in the presence of saturating free Ca 2+ , Fmin is the fluorescence intensity of fluo-5F in a solution where [Ca 2+ ] is 0, Kd is the dissociation constant of fluo-5F, and Rf is the Fmax/Fmin of fluo-5F. Kd and Rf values for fluo-5F were determined in vitro and Fmax was determined at the conclusion of each experiment with ionomycin (10 µmol/L). Fluo-5F fluorescence images were analyzed with custom software. 3 For an elevation in [Ca 2+ ]i to be considered an L-type Ca 2+ channel sparklet event, a grid of 3 x 3 contiguous pixels had to have a [Ca 2+ ]i amplitude equal to or larger than the mean basal [Ca 2+ ]i plus three times its standard deviation.
Quantal analysis of L-type Ca 2+ channel sparklet activity 3,4,6 was performed on histograms generated from individual event amplitudes. The resulting histograms were fitted with the multicomponent Gaussian function L-type Ca 2+ channel sparklet activity was determined 3, 4, 6 by calculating the nPs of each site, where n is the number of quantal levels detected, and Ps is the probability that the site is active. nPs values were obtained using pCLAMP 10 ) were calculated by dividing the number of active sites by the area of cell membrane visible in the TIRF images.
Imaging of subplasmalemmal mitochondria.
TIRF microscopy was also used to image subplasmalemmal mitochondria in isolated cells. Briefly, dispersed arterial smooth muscle cells were incubated with MitoTracker Green or MitoTracker Red CMXRos (1 µmol/L) for 15 min. Subplasmalemmal MitoTracker Green was excited with a 491 nm laser and MitoTracker Red was excited with a 561 nm laser and excitation and emission light was separated with appropriate filters. For an area of elevated MitoTracker fluorescence to be considered indicative of subplasmalemmal mitochondria the fluorescence amplitude had to be equal to or larger than the mean basal fluorescence plus three times its standard deviation. Using this criterion we generated thresholded MitoTracker TIRF images to establish clear mitochondrial boundaries. The % of plasma membrane associated with subplasmalemmal mitochondria was calculated by dividing the area of membrane associated with mitochondria by the area of plasma membrane visible. We defined mitochondrialassociated L-type Ca 2+ channel sparklet sites as those sites with peaks (pixels of highest intensity) ≤0.5 µm from the edge of the nearest thresholded MitoTracker signal.
Note that the subplasmalemmal MitoTracker fluorescence image shown in Figure 2A was obtained from a cell where we also recorded Ca 2+ influx. This required placing a glass pipette onto the top of the cell. With this experimental configuration, MitoTracker fluorescence was associated with 8.52±2.22% of the visible plasma membrane (n=5 cells). We attribute this modest increase in plasma membrane associated with mitochondria (versus 3.29±0.26% in non-patched cells; P<0.05) to the downward pressure exerted on the cell from the dorsally placed pipette. Regardless, our TIRF images indicate that subplasmalemmal mitochondria are associated with a relatively small fraction of the plasma membrane (≈5%).
Euclidean distance mapping analysis was used to quantitate the distance of observed Ca 2+ sparklet site peaks from the nearest thresholded MitoTracker signal and from 100 randomly distributed points located within visible TIRF footprint of the cells analyzed. Each cumulative distribution was fit with a single exponential function Y=Y0+(plateau-Y0)*[1-exp (-(ln2/X0.5)*X)] where Y is the cumulative frequency, Y0 is the Y value when X (distance) is zero, plateau is the Y value at infinite times, and X0.5 (halfdistance) is X where 50 % of the Y values are distal to X=zero.
Detection of reactive oxygen species generation.
TIRF microscopy was also used to visualize subplasmalemmal ROS generation as described previously by us. 4 Cells were loaded in Ca 2+ -free buffer supplemented with the cell-permeant ROS indicator 5-(and-6)-chloromethyl-2'7'-dichlorodihydrofluorescein diacetate acetyl ester (DCF; 10 µmol/L; Invitrogen) for 20 min at room temperature. Following removal of excess DCF with unsupplemented Ca 2+ -free buffer, excitation of subplasmalemmal DCF was achieved with a 491 nm laser and excitation and emission light was separated with appropriate filters. Analogous to L-type Ca 2+ channel influx, for an area of elevated DCF fluorescence to be considered a localized site of increased ROS generation (a ROS "puncta"), a grid of 3 x 3 contiguous pixels had to have a fluorescence amplitude equal to or larger than the mean basal DCF fluorescence plus three times its standard deviation. 4, 6 ROS puncta densities (ROS puncta per µm 2 ) were calculated by dividing the number of sites detected by the area of cell membrane visible in the TIRF images. Changes in DCF fluorescence (∆ DCF) were calculated from the mean pixel intensities of the total intracellular submembranous slice visible in the TIRF images (average ∆ DCF) and the areas confined to nascent ROS puncta (puncta ∆ DCF).
Intact arterial diameter measurements.
Intact arterial diameters were recorded from middle cerebral arterial segments as previously described. 4, 8 Briefly, isolated arteries were stored in ice-cold MOPS buffer containing (mmol/L): 145 NaCl, 5 KCl, 1 MgSO4, 2.5 CaCl2, 1 KH2PO4, 0.02 EDTA, 2 pyruvate, 5 glucose, 1% bovine serum albumin, and 3 MOPS (adjusted to pH 7.4 with NaOH). Arteries were transferred to a vessel chamber (Living Systems), one end of the artery was cannulated onto a glass micropipette and secured with monofilament suture and the other end was cannulated onto an opposing micropipette. Arteries were pressurized to 20 mmHg with a bicarbonate-based physiological saline solution containing (mmol/L): 119 NaCl, 4.7 KCl, 1.8 CaCl2, 1.2 MgSO4, 24 NaHCO3, 0.2 KH2PO4, 10.6 glucose, and superfused (3 mL/min) with warmed physiological saline solution (37°C) aerated with a normoxic gas mixture (21% O2, 6% CO2, balance N2). To block the effects of endothelial-derived nitric oxide, the nitric oxide synthase inhibitor N ω -nitro-L-arginine (L-NNA; 300 µmol/L) was included in the superfusate.
Following a 15-minute equilibration period, intraluminal pressure was increased to 60 mmHg, arteries were stretched to remove bends, and the pressure was lowered back to 20 mmHg for a second 15-minute equilibration period. Intraluminal pressure was then increased back to 60 mmHg and the inner diameter continuously monitored using video microscopy and edge-detection software (Ionoptix). To assess viability, all arteries were exposed to isotonic physiological saline solution containing 60 mmol/L KCl. For experiments with mitoTEMPO (Enzo Life Sciences) and TEMPOL (EMD Millipore), these antioxidants were added after a stable level of tone was obtained at 60 mmHg. Following stabilization with mitoTEMPO and TEMPOL, Ang II was added and experiments were terminated by superfusing with a nominally Ca 2+ -free physiological saline solution to obtain the passive diameter of the artery. Arterial contraction was calculated as the percentage difference in active luminal diameter versus passive luminal diameter. Passive luminal diameters were not different for our all experimental groups (P>0.05) and myogenic tone at 60 mmHg under control conditions (i.e., with only L-NNA present) in arteries from normotensive rats was also not different between all groups (P>0.05).
L-NAME-induced hypertension, mitoTEMPO infusion, and blood pressure monitoring.
Hypertension was induced in adult male Sprague Dawley rats by including N ω -nitro-L-arginine methyl ester (L-NAME; 0.75 mg/mL) in their drinking water for ten days. [9] [10] [11] [12] Daily water consumption in these rats was ≈70 mL/kg/day resulting in a dose of ≈50 mg/kg per day. Rats were also implanted with subcutaneous osmotic minipumps (Alzet) eluting mitoTEMPO (150 µg/kg per day) or saline (for control) as previously described. 13 Arterial blood pressure was monitored continuously in conscious freely moving rats by telemetry (Data Science International). Briefly, rats were anesthetized with isoflurane and a ventral midline incision through the abdominal wall was made. The intestines were manipulated with sterile cotton tip applicators to locate the abdominal aorta. Once located, the intestines were retracted using a sterile 4 x 4 gauze sponge. The overlying tissue was separated from the aorta surface, just caudal to the crossover of the left renal vein and cranial to the iliac bifurcation with sterile cotton tips and the aorta was temporary occluded with suture. A 22-gauge needle with the tip bent to a 90° angle was used to pierce the artery cranial to the iliac bifurcation and the catheter was inserted. The entry site was dried of blood and a small amount of tissue adhesive was applied to prevent leakage and maintain the catheter in place. Tension was carefully released from the occlusion suture and the catheter entry area monitored for leakage. The catheter was anchored in place using a small sterile fiber patch and secured with tissue adhesive. The transmitter was placed on top of the intestines parallel to the long axis of the body. The abdominal wall was close using non-absorbable sutures of appropriate size. An absorbable suture was used to close the skin. Osmotic minipumps were implanted concurrently to avoid additional pain and distress associated with a second survival surgery; L-NAME administration (when appropriate) was initiated ≈5 days later.
Statistics.
Statistical analyses were performed with GraphPad Prism 6 and OriginPro 8.1 software. Normally distributed data are presented as the mean±standard error of the mean (SEM). Two-sample comparisons of these data were performed using either a paired or unpaired (as appropriate) two-tailed Student's t test and comparisons between more than two groups were performed using a one way ANOVA with Tukey's multiple comparison post-test. L-type Ca 2+ channel sparklet activity (i.e. nPs) datasets were bimodally distributed, 4, 6, 8 thus two-sample comparisons of nPs data were examined with the non-parametric Wilcoxon-Mann-Whitney test (two-tailed) and comparisons between more than two groups were performed using the non-parametric Friedman test with Dunn's multiple comparison post-test. Arithmetic means of nPs datasets are indicated in the figures (solid grey horizontal lines) for non-statistical visual purposes and dashed grey lines mark the threshold for high-activity Ca 2+ sparklet sites (nPs≥0.2).
3,4,6
To account for potential variability associated with cell isolation, all single myocyte experimental groups were comprised of cells obtained from a minimum of 4 rats. Effect sizes, represented in the figures as bracketed values, are reported as Pearson's r (range -1.0 to 1.0; 0 indicates no effect). 14-17 P<0.05 were considered significant and asterisks (*) used in the figures are included to indicate significance; ns = not significantly different. mean±SEM change (∆) in the spatially averaged DCF fluorescence (average) and that of nascent ROS puncta in cells exposed to antimycin (500 nmol/L; n=5 cells).
2+
The horizontal dashed grey line represents zero change in fluorescence in response to antimycin. B, Representative TIRF images showing Ca influx in a cell before and after application of antimycin (500 nmol/L) in the presence of the H O decomposing enzyme catalase (500 U/mL) or the PKC inhibitor Gö6976 To examine the possibility that mitoTEMPO could have nonspecific inhibitory effects on L-type Ca 2+ channels we recorded macroscopic L-type Ca 2+ channel currents (using barium as the charge carrier) in the presence and absence of mitoTEMPO. Suggesting that the inhibition of L-type Ca 2+ channel sparklet activity by mitoTEMPO is not due to nonspecific perturbation of the Ca 2+ channels we found that mitoTEMPO had no apparent effect on whole-cell L-type Ca 2+ channel current amplitude or kinetics (Online Figure IIA and As an alternative to mitoTEMPO we tested the effect of the mitochondrial electron transport chain complex I inhibitor rotenone on L-type Ca 2+ channels (Online Figure IIC and D) . Acute application of nanomolar concentrations of rotenone to intact cells is associated with a decrease in mitochondrial ROS production. [18] [19] [20] iii) Subplasmalemmal mitochondria are found at sites of elevated L-type Ca 2+ channel activity
Our confocal imaging showed that mitochondria accounted for only ≈10% of the total arterial smooth muscle cell volume and only ≈10 % of this small volume was peripheral (≤0.5 µm from the plasma membrane). Therefore, the mitochondria ideally positioned to regulate L-type Ca 2+ channels represented only ≈1% of the total cell volume. With TIRF microscopy we found that ≈5% of the plasma membrane was associated with mitochondria. Although direct comparison of these values is pointless, the small amount of plasma membrane associated with mitochondria (≈5%) and the small volume occupied by peripheral mitochondria (≈1%) are in relative accord with each other.
Arterial smooth muscle cells have an average surface area of ≈1000 µm 2 . 21 Our observed L-type Ca 2+ channel sparklet densities were ≈0.04/µm 2 . As such we expect ≈40 active L-type Ca 2+ channel sparklet sites per cell. Since the spatial spread of single L-type Ca 2+ channel sparklets is ≈1 µm 2 , 6,7,22,23 we estimate that ≈40 µm 2 (only ≈4%) of the plasma membrane is associated with active L-type Ca 2+ channels. From this we conclude that the peripheral mitochondria visualized in our experiments, representing only ≈1% of the total cell volume and associated with only ≈5% of the plasma membrane, are sufficient to influence the surface area necessary (≈4%) to accommodate the L-type Ca 2+ channel sparklet activity observed.
iv) Divergent ROS signaling in arterial smooth muscle.
In contrast to our observations in this paper, work by others has shown that mitochondrial and NADPH oxidase-derived ROS reduce arterial contractility by enhancing ryanodine receptor/Ca 2+ spark-dependent activation of hyperpolarizing large-conductance, Ca 2+ -activated potassium (BK) channels. 24, 25 We contend that our H2O2 microdomain signaling hypothesis reconciles these seemingly diametrically opposed observations. In the case of our data, H2O2 microdomain signaling is coupled to the activation of L-type Ca 2+ channels which leads to contraction. Indeed, previously we provided direct evidence showing that the spatial distribution of ROS puncta mirrors that of L-type Ca 2+ channel sparklets as evident in DCF and fluo-5f fluorescence images recorded from the same cell. 4 In the case of vasodilatory-associated ROS, we hypothesize that discrete ROS signaling events, uncharacterized at present but possibly analogous to the H2O2 microdomains reported by our group (this paper and Refs 4, 8 ), are selectively coupled to vasodilatory processes. In addition, it is possible that ROS microdomain signaling attains differential coupling specificity as a consequence of distinct subcellular distribution patterns inherent to the underlying ROS generating mechanisms. Perhaps ROS signaling by peripheral mitochondria is selectively coupled to plasmalemmal L-type Ca 2+ channels while ROS generated by another mitochondrial subpopulation is selectively coupled to vasodilatory processes (e.g., Ca 2+ sparks and BK channels). Future studies are necessary to address these intriguing concepts and hypotheses.
